Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi‐metric evaluation
British Journal of Clinical Pharmacology · 2025-12 · 91 (12) · 3341-3352
DOI: 10.1002/bcp.70177 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 24.07.2025. Verfasst von Gabriela Rolová und 6 weiteren Autor:innen. Beteiligte Einrichtung: First Faculty of Medicine, Department of Addictology, Charles University, Prague, Czech Republic. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Drug Prescriptions, Drug Utilization. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Norwegian Research Council, Johannes Amos Comenius Programme (OP JAK) - MSCA Fellowship CZ - UK3, Charles University institutional support program Cooperatio (research area HEAS).
Abstract (Originalsprache)
Aims
Monitoring opioid prescribing across different healthcare systems is essential to understanding population‐level exposure and informing global health policies. This study examined opioid utilization in Scandinavian countries between 2010 and 2023 using multiple complementary metrics, addressing the limitations of single‐metric comparisons.
Methods
A repeated cross‐sectional study utilizing publicly available drug use statistics on opioid analgesics (ATC group N02A) dispensed in pharmacies from Denmark, Norway and Sweden. We assessed annual changes in utilization based on four metrics: 1‐year prevalence (users/1000 inhabitants/year), defined daily doses (DDD)/1000 inhabitants/day (TID), morphine milligram equivalents (MMEs)/TID, and MMEs/user/year.
Results
Opioid use declined in Denmark and Sweden—in both 1‐year user prevalence and volumes of MMEs—while stabilizing in Norway. Norway consistently had a higher and stable prevalence of opioid users. Denmark led in total amounts of MMEs dispensed, likely due to more frequent morphine and oxycodone use, whereas Norway ranked highest in DDDs. Denmark and Sweden showed increasing preference for “strong opioids”, while codeine‐paracetamol and tramadol remained predominant in Norway. The prevalence of oxycodone users increased in Norway and Sweden, with Sweden having the highest prevalence of users but the lowest annual average volumes per user.
Conclusions
This study found major differences in total opioid use and substance‐specific prescribing patterns, reflecting diverse pain management strategies across Scandinavia. Changing use patterns suggest evolving prescribing strategies and possible shifts in the target group for opioid pain therapy. In addition, metric‐dependent variation underscores the need for using multiple complementary metrics to accurately interpret opioid utilization trends.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Faculty of Medicine, Department of Addictology, Charles University, Prague, Czech Republic.
- Department of Addictology, General University Hospital in Prague, Prague, Czech Republic.
- University of Oslo, Norwegian Centre for Addiction Research, Oslo, Norway.
- Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Section of Palliative Medicine, Department of Oncology, Multidisciplinary Pain Centre, Department of Anaesthesiology, Pain and Respiratory Support, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
ORCID-Profile: Gabriela Rolová, Torgeir Gilje Lid
Förderung
- Norwegian Research Council
- Johannes Amos Comenius Programme (OP JAK) - MSCA Fellowship CZ - UK3
- Charles University institutional support program Cooperatio (research area HEAS)
- Norges Forskningsråd
Zitieren
APA
Rolová, G., Skurtveit, S., Handal, M., Kurita, G. P., Lid, T. G., Odsbu, I., & Hoffmann, M. (2025). Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi‐metric evaluation. British Journal of Clinical Pharmacology, 91(12), 3341-3352. https://doi.org/10.1002/bcp.70177
Vancouver
Rolová G, Skurtveit S, Handal M, Kurita GP, Lid TG, Odsbu I, et al. Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi‐metric evaluation. British Journal of Clinical Pharmacology. 2025;91(12):3341-3352. doi:10.1002/bcp.70177
BibTeX
@article{Rolov2025,
author = {Rolová, Gabriela and Skurtveit, Svetlana and Handal, Marte and Kurita, Geana Paula and Lid, Torgeir Gilje and Odsbu, Ingvild and Hoffmann, Mikael},
title = {Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi‐metric evaluation},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {12},
pages = {3341--3352},
doi = {10.1002/bcp.70177}
}
EUVIMED